Common Stock, $0.001 par value per share
- Symbol
- HTFL
- Exchange
- NASDAQ
- Classification
- COMMON
- Status
- Current
Current Report · Items 2.02, 9.01 · 8-K
Heartflow, Inc.
HTFLNASDAQEQUITYCurrent
Results of Operations and Financial Condition
Item 2.02 Results of Operations and Financial Condition . On November 12, 2026, Heartflow, Inc. issued a press release regarding its financial results for the quarter ended September 30, 2026. A copy of the press release is furnished as Exhibit 99.1 to this Form 8-K and is incorporated herein by reference.
Press release in this filing
Heartflow Reports Third Quarter 2026 Financial Results and Raises Full Year 2026 Guidance →Company context
Heartflow’s technology is redefining precision diagnostic testing and management for coronary artery disease (CAD) through clinically-proven AI and the world’s largest coronary imaging dataset. Heartflow has been adopted by more than 1,800 institutions globally and continues to strengthen its commercial presence to make this cutting-edge solution more widely available to an increasingly diverse patient population. Backed by American College of Cardiology and American Heart Association (ACC/AHA) guidelines and supported by more than 625 peer-reviewed publications, Heartflow has redefined how clinicians manage care for over 800,000 patients worldwide. 1 Key benefits include:
Current securities
Registered securities in this filing
Heartflow, Inc. · 8-K · Filed 2026-11-12
Disclosure sections
Item 2.02Item 2.02 - Results of Operations
Item 2.02
Results of Operations and Financial Condition
.
On November 12, 2026, Heartflow, Inc. issued a press release regarding its financial results for the quarter ended September 30, 2026. A copy of the press release is furnished as Exhibit 99.1 to this Form 8-K and is incorporated herein by reference.
Filed exhibits (1)
Exhibit 99.1 Heartflow Reports Third Quarter 2026 Financial Results and Raises Full Year 2026 Guidance SAN FRANCISCO - November 12, 2026 - Heartflow, Inc. (Heartflow) (Nasdaq: HTFL), the leader in AI technology for diagnosing and managing coronary artery disease (CAD), today reported financial results for the third quarter ended September 30, 2026. Third Quarter 2026 Highlights Ï Total revenue of $72.9 million, a 57% increase year-over-year Ï Gross margin of 83.6%, non-GAAP gross margin of 83.8% Ï Net operating loss of $13.8 million; non-GAAP net operating loss of $5.0 million 2026 Annual Guidance Ï Total revenue of $262 million to $264 million (approximately 49% to 50% growth year-over-year), compared to previous guidance of $246 million to $250 million (approximately 40% to 42% growth year-over-year) Ï Non-GAAP gross margin of approximately 82.5%, compared to previous guidance of approximately 82% “Our third quarter was excellent, with revenue accelerating for the third consecutive quarter and U.S. revenue growing at its fastest pace in 11 quarters,” said John Farquhar, President and CEO of Heartflow. “Our core FFRCT busi…
Open exhibit ↗